Translational Autoimmunity, Volume 5
Challenges for Autoimmune Diseases
- 1st Edition - September 13, 2022
- Latest edition
- Editor: Nima Rezaei
- Language: English
Translational Autoimmunity: Challenges for Autoimmune Diseases, Fifth Edition addresses diagnostic approaches, therapeutic opportunities, and prognostic markers of different autoim… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Key features
Key features
- Describes challenges in the diagnosis, management and treatment of autoimmune diseases
- Highlights major difficulties in the diagnosis and management of autoimmune diseases
- Reflects important remediable deficiencies in current management
- Meets the needs of basic scientists, clinicians and translational scientists and industry partners
Readership
Readership
Table of contents
Table of contents
1. Introduction on Challenges for Autoimmune Diseases
2. From horror autotoxicus to autoimmunity
3. Flow cytometry in the diagnosis of autoimmune related lymphoproliferative disorder
4. Autoantigens in atopic dermatitis: the characterization of autoantigens and their diagnostic value
5. Current paradigms and challenges in vitiligo translational research
6. The role of the kynurenine-pathway aryl hydrocarbon receptor axis in autoimmune diseases of the skin
7. COVID-19 in Childhood and Phenotypes of Pediatric Inflammatory Multisystem Syndrome
8. Challenges for epigenetics of periodontitis
9. Neutrophil extracellular traps in autoimmunity, renal diseases, and transplantation
10. Membranous nephropathy and the role of autoantibodies in its diagnosis and evolution
11. Testicular immune tolerance and viral infections
12. Ophthalmologic manifestations and management of systemic autoimmune diseases
13. Challenges for diagnosis and treatment of primary biliary cholangitis
14. Modelling autoimmune cholangiopathies as infectious disease
15. Bullous skin diseases and epitope-spreading
16. Dermatologic autoimmunity associated with immune checkpoints inhibitors
17. Insights and strategies to promote immune tolerance in allogenic hematopoietic stem cell transplantation recipients
18. The potential of cellular transplantation to harness autoimmunity and reverse clinical diabetes
Product details
Product details
- Edition: 1
- Latest edition
- Published: September 14, 2022
- Language: English
About the editor
About the editor
NR
Nima Rezaei
Nima Rezaei, MD, PhD, is Professor of Clinical Immunology and Allergy at Tehran University of Medical Sciences, where he also serves as Associate Dean of International Affairs for the School of Medicine and Director of the Global Academic Program. He is Deputy President of the Research Center for Immunodeficiencies and holds an affiliated research appointment in the Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet, Sweden. He earned his MD from Tehran University of Medical Sciences and his PhD in Clinical Immunology and Human Genetics from the University of Sheffield, United Kingdom. His research addresses primary immunodeficiencies and translational immunology, with recent work extending into computational and AI-based approaches to immune profiling. He is the founder and President of the Universal Scientific Education and Research Network (USERN) and serves as co-editor of the Springer Nature series Advances in Experimental Medicine and Biology.